As we give thanks, let's remember that support is always available—because no one should face their struggles alone. Wishing you all peace, gratitude, and strength this holiday season. If you or someone you know is struggling or in crisis, call or text the free, 24/7 National Suicide Prevention Hotline at 988.
Magnus Medical
医疗设备制造业
Burlingame,California 3,756 位关注者
We are creating the next generation of neuromodulation technology to improve quality of life rapidly and effectively.
关于我们
Magnus Medical is a privately held medical device company driven to transform lives by restoring mental health. The company is a developer of brain stimulation technology for the treatment of neuropsychiatric disorders. Its first product is the SAINT? Neuromodulation System, granted Breakthrough Device Designation and 510(k) clearance by the U.S. Food & Drug Administration (FDA) in September 2022 for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.
- 网站
-
https://www.magnusmed.com
Magnus Medical的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Burlingame,California
- 类型
- 私人持股
- 领域
- mental health和brain health
地点
-
主要
Old Bayshore Hwy
US,California,Burlingame,94010
Magnus Medical员工
动态
-
New research provides additional evidence of the effectiveness and safety of SAINT? therapy published in this recent article by Peter Tarr at Brain & Behavior Research Foundation (BBRF). Congratulations to Brandon Bentzley, MD, PhD, Nolan Williams, and team on publication of the recent trial evaluating SAINT to treat bipolar depression. https://lnkd.in/gFqRdVuE
-
Tomorrow: tune into Instagram Live at 11am PST to hear a conversation between Dr. Brandon Bentzley and Diana Daniele about the revolutionary SAINT treatment, a 5-day neuromodulation system that identifies the optimal therapy target in each person’s brain by using breakthrough algorithms with structural and functional MRI for precise, personalized treatment.
-
Magnus Medical, Inc., a pioneering therapeutic neuromodulation company transforming the treatment of neuropsychiatric disorders, today announced that the Centers for Medicare & Medicaid Services (CMS) has released the final hospital outpatient payment rates for its breakthrough SAINT? neuromodulation therapy. This important ruling significantly expands access to SAINT therapy for Medicare patients with treatment-resistant major depressive disorder (TR-MDD) in the hospital outpatient setting. Read press release: https://lnkd.in/gC7ZiKGi
-
Tune into Instagram Live on Weds, Nov 20th at 11am PST to hear a conversation between Dr. Brandon Bentzley, MD, PhD and Diana Daniele???????? about the revolutionary SAINT treatment, a 5-day neuromodulation system that identifies the optimal therapy target in each person’s brain by using breakthrough algorithms with structural and functional MRI for precise, personalized treatment.
-
New blog post from Dr. Brandon Bentzley further explores how SAINT? therapy is revolutionizing treatment for treatment-resistant major depressive disorder. Learn how this innovative approach uses advanced neuroimaging and personalized brain stimulation to provide relief for those who haven't responded to traditional treatments. #BrainHealth #Neuroscience #Depression #MDD https://lnkd.in/grH5mug2
-
Tomorrow! Register for the International Mental Health Research Symposium and tune in virtually for Dr. Nolan Williams discussion on "Breakthrough Rapid-Acting Therapeutics: Exploring Efficacy and Mechanisms in Treatment Resistant Mood Disorders" https://lnkd.in/gRpHP3wi
International Mental Health Research Symposium
bbrfoundation.org
-
The Brain & Behavior Research Foundation (BBRF), the world’s largest private funder of mental health research grants, announced it is awarding the 2024 Outstanding Achievement Prizes in Mental Health to six scientists for their exceptional work in advancing psychiatric research. The prizewinners will be the featured speakers at the BBRF International Mental Health Research Symposium on October 25, 2024, in New York City, and will receive their awards later that evening at the BBRF International Awards Dinner. Read press release: https://lnkd.in/g4pD94JQ
-
Did you know SAINT only requires 5 days of treatment at 10 sessions per day? By precisely stimulating a person’s identified target with a specialized, non-invasive pattern of repetitive magnetic pulses, SAINT effectively modifies activity in brain networks related to major depression and restores mood balance. Learn more: https://www.magnusmed.com/
-
This World Mental Health Day, learn how the SAINT neuromodulation system can identify the optimal therapy target in each person’s brain by using breakthrough algorithms with structural and functional MRI for precise, personalized treatment. By precisely stimulating a person’s identified target with a specialized, non-invasive pattern of repetitive magnetic pulses, #SAINT effectively modifies activity in brain networks related to major depression and restores mood balance: https://www.magnusmed.com/ #worldmentalhealthday #mentalhealthisbrainhealth